Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Depreciation & Amortization (CF): 2009-2024

Historic Depreciation & Amortization (CF) for Lexicon Pharmaceuticals (LXRX) over the last 16 years, with Dec 2024 value amounting to $534,000.

  • Lexicon Pharmaceuticals' Depreciation & Amortization (CF) fell 19.30% to $916,000 in Q4 2012 from the same period last year, while for Dec 2012 it was $4.2 million, marking a year-over-year decrease of 14.26%. This contributed to the annual value of $534,000 for FY2024, which is 3.61% down from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Depreciation & Amortization (CF) of $534,000 as of FY2024, which was down 3.61% from $554,000 recorded in FY2023.
  • In the past 5 years, Lexicon Pharmaceuticals' Depreciation & Amortization (CF) registered a high of $2.9 million during FY2020, and its lowest value of $292,000 during FY2021.
  • Over the past 3 years, Lexicon Pharmaceuticals' median Depreciation & Amortization (CF) value was $534,000 (recorded in 2024), while the average stood at $505,000.
  • Per our database at Business Quant, Lexicon Pharmaceuticals' Depreciation & Amortization (CF) plummeted by 90.05% in 2021 and then spiked by 46.23% in 2022.
  • Over the past 5 years, Lexicon Pharmaceuticals' Depreciation & Amortization (CF) (Yearly) stood at $2.9 million in 2020, then plummeted by 90.05% to $292,000 in 2021, then surged by 46.23% to $427,000 in 2022, then increased by 29.74% to $554,000 in 2023, then dropped by 3.61% to $534,000 in 2024.